Selective deletion of SGK1 in T cells has been shown to protect against pathology associated with an experimental model of allergic asthma by enhancing JunB ubiquitination in CD4+ T cells via a mechanism thought to involve Nedd4-2 and its adaptor Ndfip1 (ref. 50). The gene discussed is CD4; the disease is allergic asthma.